Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00324545 · ClinicalTrials.gov registry record · Phase 3
Cardiovascular Outcomes Of Diet Counseling
A Phase 3 study of Obesity and Coronary Artery Disease, sponsored by The Camelot Foundation.
- Completed
- Registry status
- Phase 3
- Development phase
- 120
- Enrollment target
- 2
- Study locations
NCT00324545: Completed Phase 3 study of Obesity and Coronary Artery Disease, sponsored by The Camelot Foundation.
NCT00324545 is a Phase 3 study of Obesity and Coronary Artery Disease that has completed, run by The Camelot Foundation. The registered enrollment target is 120 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00324545, a Phase 3 study of Obesity and Coronary Artery Disease, has completed, sponsored by The Camelot Foundation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 120 participants
- Enrollment target
- 2
- Study locations
Study Summary
(1) What effect does behavioral counseling for vegan, for low to moderate fat, and for lowered carbohydrate diets have on coronary blood flow? (2) What are the effects of different diet protocols when caloric intake and exercise are equalized? (3) Do people, so counseled, maintain their modified behaviors after they have completed their diet program? (4) How does targeting different diets affect secondary indices associated with heart disease such as weight, lipid, inflammatory, and thrombotic factors?
Conditions Studied
Interventions
- BEHAVIORAL Medium-intensity Minimally-directive Counseling
Study Locations (2)
Illinois
- Keith Block - Chicago
Nebraska
- Richard M. Fleming, MD - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2000-01-01 |
| Est. Completion | 2002-12-31 |
| Phase | Phase 3 |
What the finished NCT00324545 record still lists
NCT00324545 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (85% lower).
The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Medium-intensity Minimally-directive Counseling is the first listed.
NCT00324545 reports a single indexed study location in Illinois, Nebraska.
Frequently Asked Questions
What is clinical trial NCT00324545 about?
NCT00324545 is a clinical study titled "Cardiovascular Outcomes Of Diet Counseling". (1) What effect does behavioral counseling for vegan, for low to moderate fat, and for lowered carbohydrate diets have on coronary blood flow? (2) What are the effects of different diet protocols when caloric intake and exercise are equalized? (3) Do people, so counseled, maintain their modified beh...
What is the current status of trial NCT00324545?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 120 participants. The study started on 2000-01-01. Estimated completion is 2002-12-31.
What conditions does trial NCT00324545 study?
This clinical trial studies the following conditions: Obesity, Coronary Artery Disease.
What interventions are being tested in trial NCT00324545?
The interventions under investigation include: Medium-intensity Minimally-directive Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT00324545?
This trial is sponsored by The Camelot Foundation, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00324545 being conducted?
This trial has 2 study locations across Illinois, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00324545's enrollment target sits among peer trials
120 434th of 1053 higher than 607 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
RECRUITING · Phase 3
-
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
RECRUITING · Phase 3
-
A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight
RECRUITING · Phase 3
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Obesity or Overweight With and Without Type 2 Diabetes
RECRUITING · Phase 3
-
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and at Least One Weight-Related Comorbidity
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI